Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.


On which exchange are Biodexa Pharmaceuticals' shares traded and what is the ticker symbol?

Biodexa's American Depositary Shares trade on the NASDAQ Capital Market in the United States under the symbol BDRX (CUSIP No. 59564R609). Each American Depositary Share represents 5 Ordinary shares.

Where is Biodexa Pharmaceuticals incorporated?

Biodexa Pharmceuticals PLC is incorporated in England and Wales (registered number 09216368).

Where are Biodexa Pharmaceuticals' corporate headquarters?

Biodexa Pharmceuticals is headquartered in Cardiff, UK.

Can I purchase shares directly from the company?

No, Biodexa does not have a direct stock purchase plan. Shares may be purchased through a financial services provider of your choice.

Can I replace lost ordinary share certificates?

A new share warrant or coupon may be issued in the place of one damaged, defaced, worn out or lost (provided that no new share warrant shall be issued to replace one that has been lost unless the Board is satisfied beyond reasonable doubt that the original has been destroyed). Any enquires regarding share certificates should be addressed the Company’s Registrar, Neville Registrars.

Does Biodexa Pharmaceuticals pay a dividend?

Not at this point in time.

How can I get a copy of your Annual Report or any other Investor materials (i.e. regulatory announcements, financial calendar)?

All annual and Interim reports are posted in the Investors section of our website under “Reports and Presentations” along with other useful materials for investors.

What are American Depositary Receipts (ADRs)?

The stocks of most foreign companies that trade in the U.S. markets are traded as American Depositary Receipts (ADRs). U.S. depositary banks issue these stocks. Each ADR represents one or more shares of foreign stock or a fraction of a share. If you own an ADR, you have the right to obtain the foreign stock it represents, but U.S. investors usually find it more convenient to own the ADR. The price of an ADR corresponds to the price of the foreign stock in its home market, adjusted to the ratio of the ADRs to foreign company shares. Securities of a foreign company that are represented by an ADR are called American depositary shares (ADSs).

Why issue ADRs?

The advantages of ADRs are twofold. For individuals, ADRs are an easy and cost-effective way to buy shares in a foreign company. They save money by reducing administration costs and avoiding foreign taxes on each transaction. Foreign entities like ADRs because they get more U.S. exposure, allowing them to tap into the wealthy North American equities markets.

What types of ADR programs exist and which type does Biodexa Pharmaceuticals have?

There are three different types of ADR issues:

There are three types of ADR program (see below). Biodexa Pharmaceuticals has a Level 3 ADR program which trades on NASDAQ (ticker: MTP):

Level 1 - This is the most basic type of ADR aimed at non-U.S. companies that either don't qualify or don't wish to have their ADR listed on a U.S. stock exchange. Level 1 ADRs trade on the U.S. over-the-counter market and are an easy and inexpensive way for a company to gauge interest for its securities in the U.S.

Level 2 - This type of ADR program is listed on a U.S. stock exchange and therefore requires the issuer to adhere fully with the 2002 Sarbanes-Oxley Act, but this additional disclosure and regulation often results in greater visibility, trading volume and investor interest.

Level 3 – Like a Level 2 ADR program, a Level 3 ADR program is also listed on a U.S. stock exchange but also involves a capital-raising event in the form of ADRs. This is the ADR program that Biodexa Pharmaceuticals established in December 2015

How can I find further information about Biodexa Pharmaceuticals ADRs?

Biodexa Pharmaceuticals ADR program is administered by BNY Mellon Shareowner Services.
Please visit:

Contact details:
BNY Mellon Shareowner Services
PO Box 505000
Louisville, KY 40233-5000

Direct Mailing for overnight packages:
BNY Mellon Shareowner Services
462 South 4th Street
Suite 1600
Louisville KY


Toll free number: 1-888-BNY-ADRS (if calling from within the U.S.)
Direct Dial: +1-201-680-6825 (if calling from outside the U.S.)